Target intelligence / Profile preview

RNA, U4 small nuclear 78, pseudogene (RNU4-78P)

Target
RNU4-78P
Molecular classification
Pseudogene, Non-coding RNA (pseudogene of small nuclear RNA)
01

Overview

RNU4-78P represents a pseudogene of the U4 small nuclear RNA gene family in Homo sapiens[1][5]. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations, deletions, or truncations that prevent their expression or function[5]. RNU4-78P is similar in sequence to the U4 small nuclear RNA (snRNA), a component of the spliceosome crucial for pre-mRNA splicing, but it is not known to encode a functional RNA product or contribute directly to splicing activity[1][5]. As a pseudogene, RNU4-78P is not considered a therapeutic target, does not have a known biological function, disease association, or interacting drugs, and is generally used as a genomic reference or for studies of gene evolution[1][5]. There is nothing to suggest active involvement in disease biology, nor any clinical biomarker or safety concern. Although the functional U4 snRNA gene (e.g., RNU4-2) is implicated in neurodevelopmental disorders and the spliceosome, RNU4-78P is a pseudogene—non-functional and not a valid therapeutic or research target[1][3][5]. The only information available relates to its sequence similarity and genomic presence[1][5]. RNU4-78P should not be confused with the active RNU4-2 gene or other U4 snRNA family members involved in splicing and disease[2][3][7].

Other names
RNU4-78P

Beyond the preview

Go deeper on RNA, U4 small nuclear 78, pseudogene (RNU4-78P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 78, pseudogene (RNU4-78P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call